Home › NDC Lookup › RxCUI directory › RxCUI 197873

Levorphanol tartrate 2 MG Oral Tablet — RxCUI 197873

RxNorm drug concept · Semantic clinical drug
RxCUI 197873 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197873
Official nameLevorphanol tartrate 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)1,026 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levorphanol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levorphanol is a strong prescription opioid used to treat severe pain — the kind that hasn't been controlled by other pain medications. It's not for everyday aches or mild-to-moder...
  • Levorphanol Tartrate Tablets are typically taken every 6 to 8 hours, but your prescriber will set the exact schedule based on your pain and how you respond. You can take it with or...
  • How often do I take it, and does it matter if I take it with food?
  • The most common side effects are nausea, constipation, dizziness, drowsiness, and itching — these are typical for opioid medications and may ease as your body adjusts. What you abs...
📖 Read our full Levorphanol guide →

🕸️ Concept Web — How Levorphanol tartrate 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levorphanol tartrate 2 MG Oral Tablet RxCUI 197873

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Levorphanol 6378
    • Levorphanol tartrate 153973
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xyvona 2735119
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levorphanol Oral Tablet 372593
    • Levorphanol tartrate Oral Tablet 2646982
    • Levorphanol Oral Product 1163480
    • Levorphanol Pill 1163481
    • Levorphanol tartrate Oral Product 2662841
    • Levorphanol tartrate Pill 2662304
    • Levorphanol Oral Tablet [Xyvona] 2735123
    • Levorphanol tartrate Oral Tablet [Xyvona] 2735124
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levorphanol tartrate 2 MG 2383032
    • Levorphanol tartrate 2 MG Oral Tablet [Xyvona] 2735125
    • Levorphanol tartrate 2 MG [Xyvona] 2735120

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levorphanol tartrate 2 MG SCDC · 2383032
  • Levorphanol Oral Tablet SCDF · 372593
  • Levorphanol tartrate Oral Tablet SCDFP · 2646982
  • Levorphanol Oral Product SCDG · 1163480
  • Levorphanol Pill SCDG · 1163481
  • Levorphanol tartrate Oral Product SCDGP · 2662841
  • Levorphanol tartrate Pill SCDGP · 2662304

Brand-Name Concepts

  • Levorphanol tartrate 2 MG Oral Tablet [Xyvona] SBD · 2735125
  • Levorphanol tartrate 2 MG [Xyvona] SBDC · 2735120
  • Levorphanol Oral Tablet [Xyvona] SBDF · 2735123
  • Levorphanol tartrate Oral Tablet [Xyvona] SBDFP · 2735124
  • Xyvona Oral Product SBDG · 2735121
  • Xyvona Pill SBDG · 2735122
  • Xyvona BN · 2735119

📦 FDA Products & Package NDCs

10 products · 10 package NDCs
10 package NDCs map to RxCUI 197873 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0438-25 100 TABLET in 1 BOTTLE, PLASTIC (0054-0438-25) LEVORPHANOL TARTRATE Hikma Pharmaceuticals USA Inc. 2023-02-02
00406-2224-01 100 TABLET in 1 BOTTLE, PLASTIC (0406-2224-01) Levorphanol Tartrate SpecGx LLC 2019-12-13
00527-3236-37 100 TABLET in 1 BOTTLE (0527-3236-37) Levorphanol Tartrate Lannett Company, Inc. 2019-05-20
00527-3237-37 100 TABLET in 1 BOTTLE (0527-3237-37) Levorphanol Tartrate Lannett Company, Inc. 2021-01-12
57664-0058-88 100 TABLET in 1 BOTTLE (57664-058-88) Levorphanol Tartrate Sun Pharmaceutical Industries, Inc. 2024-06-15
57664-0762-88 100 TABLET in 1 BOTTLE (57664-762-88) Levorphanol Tartrate Sun Pharmaceutical Industries, Inc. 2022-04-26
63629-2093-01 100 TABLET in 1 BOTTLE (63629-2093-1) Levorphanol Tartrate Bryant Ranch Prepack 2024-08-08
69543-0417-10 100 TABLET in 1 BOTTLE (69543-417-10) Levorphanol Tartrate Virtus Pharmaceuticals, LLC 2020-09-01
72162-2309-01 100 TABLET in 1 BOTTLE (72162-2309-1) Levorphanol Tartrate Bryant Ranch Prepack 2024-05-07
72989-0417-10 100 TABLET in 1 BOTTLE (72989-417-10) Levorphanol Tartrate ACERTIS PHARMACEUTICALS, LLC 2025-07-14
Observed labelers: Bryant Ranch Prepack (2) · Lannett Company, Inc. (2) · Sun Pharmaceutical Industries, Inc. (2) · ACERTIS PHARMACEUTICALS, LLC (1) · Hikma Pharmaceuticals USA Inc. (1) · SpecGx LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.